Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1992-05-29
1994-08-16
Knode, Marian
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4352521, 435870, 424825, A61K 3902
Patent
active
053385438
ABSTRACT:
The invention relates to a method for making an inactivated vaccine of Mycoplasma hyopneumoniae by inactivating the bacteria with Thimerosal. The resulting bacterin is mixed with an adjuvant of aluminum hydroxide and DEAE dextran and injected into pigs. The resulting bacterin and adjuvant mixture can also be mixed with other bacteria such as Borderella and Pasteurella, for further adjuvant effect. Protective immunity against mycoplasmal pneumonia is elicited in swine using these vaccines.
REFERENCES:
patent: 2908614 (1959-10-01), Muggleton et al.
patent: 3522790 (1970-10-01), Greegberg et al.
patent: 3632741 (1972-01-01), Wittmann et al.
patent: 3917819 (1975-11-01), Yoshioka et al.
patent: 4058599 (1977-11-01), Bauer
patent: 4855227 (1989-08-01), McGarrity
patent: 4894332 (1990-11-01), Schaller et al.
patent: 4985243 (1991-01-01), Faulds et al.
patent: 5004607 (1991-04-01), Ragland et al.
patent: 5064647 (1991-11-01), Storm
Chen, K. S. et al., "Adjuvant Enhancement of Humoral Immune Response to Chemically Inactivated Bovine Viral Diarrhea Virus", Canadian Journal of Comparative Medicine, 49:91-94 (Jan. 1985).
Gupta, R et al., "Effects of Elevated Temperatures on the Opacity and Toxicity of Pertussis Vaccines Manufactured with Different Inactivating Agents", Biological Abstracts 82(11): 102519 1986.
Mirchamsy, H. A. et al., "Active Immunization of Cattle with Killed Vaccines Prepared from Cell-Cultural Rinderpest Virus", Biological Abstracts 62(8):43171 1976.
Petersen et al, Proc. Amer. Assoc. Swine Pract., Mar. 1991, pp. 17-21.
Wise et al., Journal of Bacteriology, 169: 5546-5555 (1987).
Dayalu, Proceedings: Mycoplasma Pneumonia Symposium, Smith Kline Beecham, 1-15 (1990).
Kishima et al, Veterinary Microbiology, 13: 335-42 (1987).
Fitzgerald Gerald R.
Welter C. Joseph
Ambico Inc.
Cooper Iver P.
Knode Marian
LandOfFree
Thimerosal inactivated mycoplasma hyopneumoniae vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Thimerosal inactivated mycoplasma hyopneumoniae vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Thimerosal inactivated mycoplasma hyopneumoniae vaccine will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-950386